Research project of multi-acupoint co-effect and synergistic clinical program

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Subjects aged 18-70 years old;
•2. Subjects with IBS according to Rome IV diagnostic criteria;
•3. Patients with a course of at least 6 months;
•4. Patients with IBS symptom severity score > 75 at baseline;
•5. Patients with normal occult blood in stool in recent one month;
•6. Subjects who voluntarily participated in this trial and signed informed consent.
•Note: all the above conditions were met before inclusion.

•1. Patients with intestinal organic lesions (including but not limited to ulcerative colitis and colorectal cancer) found by previous colonoscopy, barium meal fluoroscopy and abdominal ultrasound;
•2. Patients with one or more of the following warning symptoms: hematochezia, fecal occult blood test positive, anemia, abdominal mass, ascites, fever, weight loss;
•3. Patients with severe diseases of cardiovascular system, endocrine system and rheumatic immune system that affect the judgment of disease condition;
•4. The patients with unconsciousness, inability to express subjective discomfort symptoms and severe mental disorder diagnosed clearly;
•5. Patients with severe depression (SDS total score > 56);
•6. Pregnant or lactating women;
•7. Patients who have received acupuncture treatment for IBS in recent three months;
•Note: patients who meet any one of the above criteria are excluded.

发起方

Beijing University of Chinese Medicine